Royal Stoke University Hospital is a teaching and research hospital at Hartshill in the English county of Staffordshire. It lies in the city of Stoke-on-Trent, near the border with Newcastle-under-Lyme, and is one of the largest hospitals in the country and a major local employer, with over 6,000 staff.

There are 1,328 beds in University Hospital of North Staffordshire.

During the past decade, University Hospital of North Staffordshire conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 2 clinical trials were completed, i.e. on average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University Hospital of North Staffordshire" #1 sponsor was "Institute of Cancer Research, United Kingdom" with 3 trials, followed by "University College, London" with 3 trials sponsored, "Medical Research Council" with 2 trials sponsored, "Velindre NHS Trust" with 2 trials sponsored and "Anaxsys Technology Ltd" with 2 trials sponsored. Other sponsors include 10 different institutions and companies that sponsored additional 20 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University Hospital of North Staffordshire" #1 collaborator was "Queen Mary University of London" with 3 trials as a collaborator, "University of Edinburgh" with 2 trials as a collaborator, "University of Leeds" with 2 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator and "Canadian Cancer Trials Group" with 1 trials as a collaborator. Other collaborators include 10 different institutions and companies that were collaborators in the rest 20 trials.

According to Clinical.Site data, the most researched conditions in "University Hospital of North Staffordshire" are "Breast Cancer" (3 trials), "Colorectal Cancer" (2 trials), "Head and Neck Cancer" (2 trials), "Lymphoma" (2 trials) and "Acute Coronary Syndromes" (1 trials). Many other conditions were trialed in "University Hospital of North Staffordshire" in a lesser frequency.

Most popular intervention types in "University Hospital of North Staffordshire" are "Drug" (17 trials), "Biological" (9 trials), "Procedure" (6 trials), "Radiation" (4 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "adjuvant therapy" (4 trials), "capecitabine" (4 trials), "cyclophosphamide" (3 trials) and "fluorouracil" (3 trials). Other intervention names were less common.

The vast majority of trials in "University Hospital of North Staffordshire" are 21 trials for "All" genders, 4 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "University Hospital of North Staffordshire". undefined are not yet recruiting, undefined are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 16 completed trials in University Hospital of North Staffordshire, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in University Hospital of North Staffordshire, 0 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".